Your browser doesn't support javascript.
loading
Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer.
Al Amri, Waleed S; Allinson, Lisa M; Baxter, Diana E; Bell, Sandra M; Hanby, Andrew M; Jones, Stacey J; Shaaban, Abeer M; Stead, Lucy F; Verghese, Eldo T; Hughes, Thomas A.
Afiliação
  • Al Amri WS; School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Allinson LM; Department of Histopathology and Cytopathology, The Royal Hospital, Muscat, Oman.
  • Baxter DE; School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Bell SM; School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Hanby AM; School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Jones SJ; School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Shaaban AM; Department of Histopathology, St. James's University Hospital, Leeds, United Kingdom.
  • Stead LF; Department of Breast Surgery, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Verghese ET; Histopathology and Cancer Sciences, Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, United Kingdom.
  • Hughes TA; School of Medicine, University of Leeds, Leeds, United Kingdom.
Mol Cancer Ther ; 19(3): 945-955, 2020 03.
Article em En | MEDLINE | ID: mdl-31879365

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Proteínas de Ciclo Celular / Resistencia a Medicamentos Antineoplásicos / Mucinas / Mutação Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Proteínas de Ciclo Celular / Resistencia a Medicamentos Antineoplásicos / Mucinas / Mutação Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article